CUC 2022 Webcast: Insulin Therapy Updates

Overview

Objectives:

Discuss key recommendations from the 2022 ADA Standards of Medical Care in Diabetes related to use of non-insulin glucose-lowering therapies;
Review key safety, tolerability, and risk-mitigation strategies to consider with non-insulin glucose-lowering therapies; and
Emphasize the importance of diabetes self-management education to optimize use of non-insulin therapies.

Speaker:

Richard S. Beaser, MD

Medical Director of Continuing Medical Education

Senior Strategic Advisor, Education Programs. Joslin Diabetes Center

Associate Professor of Medicine, Harvard Medical School

Summary


Cost:	Member: $10.00 Non-Member: $15.00


Credit Offered:	0.75 CME Credit 0.75 ABIM-MOC Point 0.75 ACPE Credit 0.75 ANCC Credit 0.75 AAPA Credit 0.75 CDR Credit 0.75 COP Credit

Create Account